# CLX — Clorox · catalysts, narrative & risks

**Deep-research report — K3vl4r**  
**Symbols:** CLX  
**Sources:** 27  
**Published:** 2026-10-01  
**Canonical:** https://app.k3vl4r.com/research/deep-research-clx-clorox-catalysts-narrative-risks-5552

---

## Clorox (NYSE: CLX) — Research Snapshot as of 2026-10-01

**Quick facts:** CLX trades around **$80.65** on the NYSE as of October 1, 2026 [[23]](https://midforex.com/stocks/clx-forecast), [[25]](https://stockanalysis.com/stocks/clx/), near the low end of its 52-week range ($79.12–$128.90) [[23]](https://midforex.com/stocks/clx-forecast), [[25]](https://stockanalysis.com/stocks/clx/). Market capitalization is roughly **$9.75–9.9 billion** [[25]](https://stockanalysis.com/stocks/clx/), [[4]](https://ad-hoc-news.de/boerse/news/corporate-news/the-clorox-company-stock-trades-at-eur-72-09-with-a-plus-0-21-percent/70203490), with a P/E of ~16.8x, forward P/E ~14.0x, dividend of $5.00 (≈6.2% yield) [[25]](https://stockanalysis.com/stocks/clx/), [[16]](https://www.marketbeat.com/instant-alerts/price-clorox-nyse-clx-sets-new-1-year-low-should-you-sell-2026-09-30/). Clorox's fiscal year ends ~June 30, so FY2026 closed June 30, 2026, with Q4 results reported August 3, 2026, and the November report being Q1 FY2027 [[10]](https://finance.yahoo.com/markets/stocks/articles/clorox-company-stock-clx-underperforming-144929119.html), [[25]](https://stockanalysis.com/stocks/clx/).

---

---

_Preview only. The complete multi-source deep-research report — full thesis, evidence, and citations — is available at https://app.k3vl4r.com/research/deep-research-clx-clorox-catalysts-narrative-risks-5552 (free to sign up)._